ArticleFrontiers in oncology2025

COP1 drives renal cell carcinoma progression by targeting ACSL4 for ubiquitin-mediated degradation and inhibiting ferroptosis.

Yuxiao Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.